Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Decoy Therapeutics Inc., 3 years.
Decoy Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Decoy Therapeutics Inc. December 20, 202491.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | Decoy Therapeutics Inc. | Grant or award | +2,000 | — | — |
| Jan 3, 2023 | Decoy Therapeutics Inc. | Grant or award | +1,440 | — | — |
Questions about Tess Burleson
What boards is Tess Burleson on?
Tess Burleson sits on the board of Decoy Therapeutics Inc.
How long has Tess Burleson served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.